PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. 13D and 13G filings for Harvard Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 4:06 pm Sale |
2025-03-31 | 13G | Harvard Bioscience, Inc. HBIO |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 25,586 0.100% |
-2,892,448 (-99.12%) |
Filing |
| 2024-02-14 09:00 am Purchase |
2023-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 2,918,034 6.800% |
153,995 (+5.57%) |
Filing |
| 2023-02-13 5:12 pm Purchase |
2022-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 2,764,039 6.640% |
597,264 (+27.56%) |
Filing |
| 2022-02-14 11:02 am Purchase |
2021-12-31 | 13G | Harvard Bioscience, Inc. HBIO |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 2,166,775 5.310% |
2,166,775 (New Position) |
Filing |